The study presents an explainable multimodal deep‑learning framework that combines a 3D CNN for T1‑weighted MRI with a feedforward network for harmonized clinical and demographic data to diagnose Alzheimer’s disease. Using 6,479 ADNI records and 1,703 OASIS‑3 records, the authors compare various model configurations on three‑way and pairwise diagnostic tasks, finding that performance and explanations vary by task, modality, fusion strategy, and cohort. SHAP and Integrated Gradients consistently highlight the MMSE score as the most influential tabular feature, while CAM‑based explanations differ across model setups and cohorts, indicating that explainability is not a stable property under cohort shift.
arXiv:2606. 20037v1 Announce Type: new Abstract: Alzheimer's disease (AD) is an irreversible neurodegenerative disorder and a leading cause of death worldwide.
arXiv:2609.15888v1 Announce Type: cross Abstract: Deep networks trained on structural MRI for Alzheimer's disease (AD) staging often reach reasonable accuracy while attending to anatomically irreleva...
The paper introduces TAFNet, a temporal attention fusion network that uses both a baseline and a follow‑up T1‑weighted brain scan to predict which individuals with mild cognitive impairment (MCI) will progress to dementia. The model employs a pretrained Siamese encoder for each scan and fuses the two scans through anatomical difference, cross‑temporal attention, joint context, and a learned per‑patient gate. Evaluated on paired scans from the Alzheimer’s Disease Neuroimaging Initiative, TAFNet outperforms single‑scan networks and a simple scan‑difference model, achieving significant gains in cross‑validation and maintaining high sensitivity at clinically reasonable specificity.
The study investigates whether a compact, supervised 3D CNN pretrained for brain‑age prediction can act as a reusable foundation model for various Alzheimer's‑related neuroimaging tasks. By freezing the 7.18 million weights and adding only ~1 % of trainable parameters via Low‑Rank Adaptation, the model achieved high performance across six experiments, including dementia classification, MCI progression prediction, amyloid positivity detection, and volume estimation of hippocampal and white matter hypointensities. The results demonstrate that the pretrained brain‑age model generalizes well to new datasets without retraining, offering a data‑efficient alternative to larger networks.
M$^2$PFN is an end‑to‑end multimodal framework that extends the TabPFN in‑context learning engine to Alzheimer’s disease diagnosis by aligning 3D‑MRI and tabular features in a shared subspace. It performs differentiable inference through TabPFN’s transformer, back‑propagates gradients into the encoders, and incorporates a frozen tabular‑only prediction via a gated shortcut. On the ADNI cohort it achieves 65.55 % macro‑F1 and 82.21 % macro‑AUC, surpassing unimodal and multimodal baselines, and it generalizes to external cohorts without retraining.
arXiv:2607. 07091v1 Announce Type: cross Abstract: In longitudinal Alzheimer's disease (AD) diagnosis support, clinical and imaging information is often collected at irregular visits.
In longitudinal Alzheimer's disease (AD) diagnosis support, clinical and imaging information is often collected at irregular visits. Integrating these multimodal observations may improve diagnostic assessment, but naive fusion can degrade performance when MRI is noisy or intermittently unavailable.
The paper introduces a leakage‑controlled multimodal learning framework for diagnosing and predicting the progression of Alzheimer’s disease. It combines an adapted SFCN MRI encoder, four causal clinical Transformers, shared fusion, and task‑specific ODE‑GRU dynamics, with fine‑tuning and LoRA for MRI blocks. Across 2,649 subjects and 17,317 visits, the model achieves high AUROCs for diagnosis and progression, and demonstrates strong external validation on OASIS‑3 data.
arXiv:2606. 11794v1 Announce Type: cross Abstract: Neurodegenerative diseases such as Alzheimer's disease (AD) require accurate and scalable tools for assessing disease severity, yet current clinical staging remains time-intensive and prone to variability.
The paper presents a multimodal 3D convolutional neural network that classifies Alzheimer’s disease using raw OASIS 1 MRI volumes. It fuses structural T1 images with gray matter, white matter, and cerebrospinal fluid probability maps to capture complementary neuroanatomical information. Evaluated with 5‑fold subject‑level cross‑validation, the model achieves a mean accuracy of 72.34 % and an ROC AUC of 0.7781, with GradCAM visualizations highlighting anatomically relevant regions such as the medial temporal lobe and ventricles.
arXiv:2607. 11656v1 Announce Type: cross Abstract: Accurate diagnostic classification and disease-severity prediction for Alzheimer's disease are hampered by the incompleteness and heterogeneity of real-world clinical data.
The paper introduces MCNet, a neural network that assigns a Modality Contribution Score (MCS) to each patient, indicating how much structural MRI versus amyloid PET drives the diagnostic decision for Alzheimer’s disease. Across 327 ADNI-3 participants, MCNet achieved strong three‑class staging (AUC = 0.881) and the MCS showed a clear, statistically significant increase in PET dominance from cognitively normal to AD. The method was validated on an independent OASIS‑3 cohort and compared favorably to SHAP, suggesting it can guide personalized imaging and clinical trial decisions.